Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
G protein-coupled receptors (GPCRs) compose the largest family of cell surface receptors and are the most common target of therapeutic drugs. The nonvisual arrestins, β-arrestin-1 and β-arrestin-2, are multifunctional scaffolding proteins that play critical roles in GPCR signaling. On binding of activated GPCRs at the plasma membrane, β-arrestins terminate G protein-dependent responses (desensitization) and stimulate β-arrestin-dependent signaling pathways. Alterations in the cellular complement of β-arrestin-1 and β-arrestin-2 occur in many human diseases, and their genetic ablation in mice has severe consequences. Surprisingly, however, the factors that control β-arrestin gene expression are poorly understood. We demonstrate that glucocorticoids differentially regulate β-arrestin-1 and β-arrestin-2 gene expression in multiple cell types. Glucocorticoids act via the glucocorticoid receptor (GR) to induce the synthesis of β-arrestin-1 and repress the expression of β-arrestin-2. Glucocorticoid-dependent regulation involves the recruitment of ligand-activated glucocorticoid receptors to conserved and functional glucocorticoid response elements in intron-1 of the β-arrestin-1 gene and intron-11 of the β-arrestin-2 gene. In human lung adenocarcinoma cells, the increased expression of β-arrestin-1 after glucocorticoid treatment impairs G protein-dependent activation of inositol phosphate signaling while enhancing β-arrestin-1-dependent stimulation of the MAPK pathway by protease activated receptor 1. These studies demonstrate that glucocorticoids redirect the signaling profile of GPCRs via alterations in β-arrestin gene expression, revealing a paradigm for cross-talk between nuclear and cell surface receptors and a mechanism by which glucocorticoids alter the clinical efficacy of GPCR-based drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, glucocorticoid induction of b-arrestin 1 and repression of b-arrestin 2 occurs through an intron 1 GRE and an intron 11 nGRE, respectively 23.”
From Corticosteroids (2016) · cites this paper as [23]
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 1×
“Because of their powerful anti-inflammatory and immunosuppressive actions, synthetic glucocorticoids are one of the most widely prescribed drugs worldwide, serving as mainstays in the treatment of acute and chronic inflammatory diseases, autoimmune diseases, organ transplant rejection, and cancers of the lymphoid syst…”
BackgroundSelf-citationTransduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
β-Arrestins and Cell Signaling
DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
β-arrestin-mediated receptor trafficking and signal transduction
Shenoy, S. K., & Lefkowitz, R. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.002 · Cited by 712
Surjit, M., Ganti, K. P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., & Chambon, P. (2011) · Cell · doi:10.1016/j.cell.2011.03.027 · Cited by 551 · cited 1×
“Our search of the β-arrestin-2 gene for GR-binding sites did not reveal a classic GRE; however, it did uncover five sites with high homology to the inverted repeat negative GRE (nGRE), which was recently reported to mediate glucocorticoid-dependent repression of many target genes (17).”
BackgroundReddy, T. E., Pauli, F., Sprouse, R. O., Neff, N. F., Newberry, K. M., Garabedian, M. J., & Myers, R. M. (2009) · Genome Research · doi:10.1101/gr.097022.109 · Cited by 543
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Oakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373 · cited 1×
“Glucocorticoids are primary stress hormones that regulate a plethora of biological processes and function to maintain homeostasis (12).”
BackgroundSelf-citationBeyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
Target validation of G-protein coupled receptors
Wise, A., Gearing, K., & Rees, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02131-6 · Cited by 359
Wang, J.-C., Derynck, M. K., Nonaka, D. F., Khodabakhsh, D. B., Haqq, C., & Yamamoto, K. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407008101 · Cited by 320
Determinants of Cell- and Gene-Specific Transcriptional Regulation by the Glucocorticoid Receptor
So, A. Y.-L., Chaivorapol, C., Bolton, E. C., Li, H., & Yamamoto, K. R. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030094 · Cited by 305
Paing, M. M., Stutts, A. B., Kohout, T. A., Lefkowitz, R. J., & Trejo, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109160200 · Cited by 229
Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance
Luan, B., Zhao, J., Wu, H., Duan, B., Shu, G., Wang, X., Li, D., Jia, W., Kang, J., & Pei, G. (2009) · Nature · doi:10.1038/nature07617 · Cited by 217
β-Arrestin-2 regulates the development of allergic asthma
Walker, J. K. L., Fong, A. M., Lawson, B. L., Savov, J. D., Patel, D. D., Schwartz, D. A., & Lefkowitz, R. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17265 · Cited by 198
Critical regulation of CD4+ T cell survival and autoimmunity by β-arrestin 1
Shi, Y., Feng, Y., Kang, J., Liu, C., Li, Z., Li, D., Cao, W., Qiu, J., Guo, Z., Bi, E., et al. (2007) · Nature Immunology · doi:10.1038/ni1489 · Cited by 141
Biochemical Basis of Asthma Therapy
Barnes, P. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.206466 · Cited by 136
Protease-activated receptors as drug targets in inflammation and pain
Vergnolle, N. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.004 · Cited by 132
Archacki, S. R., Angheloiu, G., Tian, X.-L., Tan, F. L., DiPaola, N., Shen, G.-Q., Moravec, C., Ellis, S., Topol, E. J., & Wang, Q. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00181.2002 · Cited by 93
Chen, C.-H., Paing, M. M., & Trejo, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310590200 · Cited by 76
Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia
Бычков, Э. Р., Gurevich, V. V., Joyce, J. N., Benovic, J., & Gurevich, E. V. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.012 · Cited by 76
Hershko, D. D., Robb, B. W., Wray, C. J., Luo, G., & Hasselgren, P. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20014 · Cited by 57
Kuo, F., Lu, T., & Fu, H. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.02.009 · Cited by 24
Elevated β-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia
Liu, H., Long, J., Zhang, P., Li, K., Tan, J., Sun, B., Yu, J. Z., Tu, Z., & Zou, L. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0824-9 · Cited by 19
Schmidt, M., & Michel, M. C. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.075481 · Cited by 9
Cited by
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
“By altering the ratio of βarrestin1 and βarrestin2, glucocorticoids shift the balance of G protein and βarrestin-dependent signaling responses for a given GPCR (31).”
BackgroundInfluentialGlucocorticoid receptor signaling in health and disease
Kadmiel, M., & Cidlowski, J. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.003 · Cited by 849
“Furthermore, knockdown of HDAC2 correlated with decreased sensitivity to corticosteroid treatment in primary alveolar macrophages, and overexpression of HDAC2 in alveolar macrophages from COPD patients exhibiting glucocorticoid resistance reestablished their sensitivity to glucocorticoid therapy [24].”
BackgroundInfluentialSelf-citationRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Self-citationGlucocorticoid receptor action in metabolic and neuronal function
Garabedian, M. J., Harris, C. A., & Jeanneteau, F. D. (2017) · F1000Research · doi:10.12688/f1000research.11375.1 · Cited by 75
Borroto‐Escuela, D. O., Hinz, S., Navarro, G., Franco, R., Müller, C. E., & Fuxé, K. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00043 · Cited by 73
“Interestingly, recent work demonstrated that the GR binds to GREs in β-arrestin 1 and 2 and modulates their gene expression (Oakley et al., 2012) which will became reduced by the A2AR-GR heteroreceptor complex.”
Background
Metadata
- Authors
- Oakley, R. H., Revollo, J., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-10-08
- Volume
- 109
- Issue
- 43
- Pages
- 17591-17596
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3491462
- OpenAlex
- W1974786948
- Cited by
- 55
- References
- 26
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 4
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- glucocorticoids, β-arrestin1, β-arrestin2, G protein-coupled receptors, glucocorticoid receptor, gene expression regulation, glucocorticoid response element, receptor desensitization, MAPK signaling, protease-activated receptor 1, inositol phosphate signaling, lung adenocarcinoma cells
- MeSH terms
- beta-Arrestins, beta-Arrestin 1, beta-Arrestin 2, Gene Expression Regulation, Glucocorticoids, Humans, RNA, Messenger, Signal Transduction, Arrestins, Reverse Transcriptase Polymerase Chain Reaction, Receptors, G-Protein-Coupled, Cell Line, Tumor, Chromatin Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.